Skip to main content
Clinical Trials/ACTRN12618001904268
ACTRN12618001904268
Completed
未知

A cluster randomised controlled trial to evaluate the impact using a sterile surgical skin marker, to indicate the location of the optimal vein for venepuncture, has on Phlebotomy success in the Australian blood donation setting

Australian Red Cross Blood Service0 sites13,730 target enrollmentNovember 22, 2018

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Australian Red Cross Blood Service
Enrollment
13730
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 22, 2018
End Date
February 14, 2019
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. A mean phlebotomy success rate of less than 95%
  • 2\. Sufficient size to recruit over 700 donors over a month
  • 3\. Static Donor Centres
  • PARTICIPANTS
  • 1\. Adults greater than 18 years of age
  • 2\. Eligible for blood donation as per the current 'Guidelines for the Selection of Blood Donors'

Exclusion Criteria

  • 1\. Plasma only donor centres
  • 2\. Donor Mobile units (DMUs) and Demountable mobile units
  • 3\. Participation in another research study (R\&D or Marketing) that may interfere with donor recruitment and the outcomes under investigation
  • 4\. Donor Services Leadership team consider the donor centre not appropriate for participation (e.g.: centre undergoing renovations, relocation)
  • PARTICIPANTS
  • 1\. Donors booked for sample only collections and ineligible to proceed to donation (e.g.: ABMDR, HOH, venous ferritin)
  • 2\. Known sensitivity to Gentian violet and or other topical disinfectants
  • 3\. Donors who decline use of the skin marker

Outcomes

Primary Outcomes

Not specified

Similar Trials